Patient X, a 62-year-old male, is scheduled to undergo surgery for a knee replacement due to severe osteoarthritis. His medical history includes hypertension, hyperlipidemia, type 2 diabetes mellitus, and chronic obstructive pulmonary disease (COPD). He has a significant smoking history of 40 pack-years and is currently on albuterol inhaler therapy.

His hypertension has been well controlled with lisinopril 20 mg daily, and his hyperlipidemia is managed with atorvastatin 40 mg daily, resulting in stable blood pressure and lipid profiles. Patient X's diabetes is well managed with metformin 1000 mg twice daily, and his HbA1c levels have consistently been below 7%. He has a history of mild peripheral neuropathy from his diabetes and takes gabapentin 300 mg three times daily for pain control. 

Patient X's COPD is mainly managed with the albuterol inhaler and regular pulmonary function tests show moderate airflow limitation. He has required oral corticosteroids intermittently during acute exacerbations. He admits to being a former heavy smoker but hasn't smoked in 18 months. His oxygen saturation levels remain above 93% on room air. 

Taking a thorough medication history, Patient X takes aspirin 81 mg daily as prophylaxis for cardiovascular disease, and has been advised to stop it a week before the surgery. He also supplements his diet with a daily multivitamin and glucosamine-chondroitin for his joint health. He denies any drug allergies or adverse drug reactions.

On physical examination, Patient X's vital signs are stable with a blood pressure of 130/80 mmHg, a heart rate of 80 beats per minute, a respiratory rate of 16 breaths per minute, and a temperature of 98.6°F. His body mass index is 31 kg/m², indicating obesity. Auscultation reveals regular heart sounds without murmurs, equal breath sounds bilaterally, and no wheezing or crackles.

Preoperative investigations, including complete blood count and coagulation profile, liver and renal function tests, and electrocardiogram, are within normal limits. Chest X-ray shows mild hyperinflation and minimal bronchial wall thickening, consistent with COPD.

Patient X's surgery was performed without complications, and he received spinal anesthesia. Intraoperatively, no significant bleeding or hemodynamic instability was observed. A total knee replacement was successfully completed, and the patient was transferred to the post-anesthesia care unit (PACU) in a stable condition.

During his postoperative course, Patient X experienced mild pain, which was successfully managed with oral analgesics. Physical therapy was initiated within 24 hours of surgery, focusing on early mobilization and strengthening exercises. His vital signs remained stable, and he was able to tolerate a regular diet without any gastrointestinal complaints.

Within two days of the surgery, Patient X was able to ambulate with the assistance of a walker and reported improved mobility and reduced knee pain. His surgical wound was clean and well-approximated without signs of infection or dehiscence. He was discharged home on the fourth postoperative day with a prescription for oral opioids for pain management and instructions for outpatient physical therapy sessions.

Patient X's postoperative course was uneventful, with no major complications observed. However, ongoing close monitoring of his blood glucose levels was advised due to the stress of surgery and the potential impact on his diabetes management. The patient was also informed about the signs and symptoms of deep vein thrombosis and advised on preventive measures, such as early mobilization, leg exercises, and wearing compression stockings.

In summary, Patient X, a 62-year-old male with a history of hypertension, hyperlipidemia, type 2 diabetes mellitus, and COPD, underwent successful knee replacement surgery without complications. His postoperative course was uneventful, and he showed significant improvement in pain and mobility. Close monitoring of his diabetes management and thromboembolic prophylaxis were recommended during his recovery period.